About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Combination of Vaccine and Checkpoint Drugs to Treat Pancreatic Cancer

by Ramya Rachamanti on December 19, 2018 at 2:16 PM
Font : A-A+

Combination of Vaccine and Checkpoint Drugs to Treat Pancreatic Cancer

Combination of a cancer vaccine with two checkpoint drugs reduced pancreatic cancer tumors in mice, according to the researchers of the Johns Hopkins Kimmel Cancer Center.

They demonstrated a possible pathway for treating patients with pancreatic cancers whose response to standard immunotherapy is poor.

Advertisement


Results of the experiments combining an immune system booster vaccine called PancVAX with two checkpoint drugs derived from anti-PD-1 and agonist OX40 antibodies were published in the journal JCI Insight.

The findings showed by using PancVAX with the checkpoint drugs, pancreatic tumors had a better response to therapy by converting T cell-poor tumors into tumors that are rich in specific T cells. T cells are critical cells of the immune system to recognize and kill cancer cells.
Advertisement

Because T cell deficiencies are common in pancreatic and other kinds of cancers with fewer genetic mutations, researchers in recent years have increasingly experimented with immunotherapy drugs that -- individually -- draw only a weak response, but in combination appear to work better.

Corresponding author Neeha Zaidi, M.D., an oncology fellow at the Kimmel Cancer Center, said one major challenge is to find ways to induce T cells to get into the tumor microenvironment, and her team's latest experiments add to evidence that tumor vaccines in combination with checkpoint modulators may be an effective way to achieve this.

"The vaccine tunes in the signal of the tumor for therapy, and the checkpoint drugs amplify the signal to teach the immune system to go after the tumor," Zaidi said. "This framework is a personalized strategy to go after pancreatic and other nonimmunogenic cancers."

After the mice received the combination treatment and had their tumors cleared, reintroduction of tumor cells did not develop, indicating a memory of the T cells to target the cancer.

Elizabeth Jaffee, M.D., senior author of the study and deputy director of the Kimmel Cancer Center, said the combination approach has promise for patients who are or become resistant to immunotherapy drugs after a recurrence of their tumors.

But she cautioned that more animal studies and clinical trials for safety and value will be needed before the combination can be used in humans. The combination is not currently available to people, and potential costs are unknown.

"We have already seen some promise with current vaccines being tested in patients with this cancer," Jaffee said. "We now have the next generation of vaccines that are more specific to each patient's own cancer, and we have reason to hope that a combination drug approach will offer more to patients."

Pancreatic cancer is a particularly challenging disease, because there are many barriers to generating a robust immune response within the tumor. Zaidi said there are plans for pilot clinical trials for pancreatic cancer patients with advanced cancers within the next year or so.

According to the National Cancer Institute, deaths from pancreatic cancer accounted for more than 7 percent of all cancer deaths in 2018. It remains one of the most lethal malignancies because by the time it is diagnosed, it has generally spread beyond its original site.

Pancreatic cancer is the fourth leading cause of deaths due to cancer in the United States, with a median survival of less than six months.

Corresponding author Mark Yarchoan, M.D., assistant professor of oncology at the Kimmel Cancer Center, said, "This work is very exciting and supports further testing of this treatment combination in patients with pancreatic cancer, and perhaps other cancers as well that have so far not responded to immune checkpoint inhibitor therapies."



Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Category
What's New on Medindia
World Heart Day 2021 -
Are Black Foods the New Superfood?
Ten Fruits for Diabetics
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Pancreatic Cancer Drug Toxicity Cancer and Homeopathy Cancer Facts Cancer Tattoos A Body Art Pancreatitis Drugs Banned in India Vaccination for Children Common Lifestyle Habits that Cause Diseases 

Recommended Reading
Pancreatic Cancer
Pancreatic cancer often involves its exocrine part. It grows aggressively, and often detected late. ...
Common Lifestyle Habits that Cause Diseases
Cigarette smoking, unhealthy diets, overuse of alcohol, and physical inactivity are some of the most...
Drug Toxicity
Drug toxicity is an adverse reaction of the body towards a drug that results as a side effect of a d...
Drugs Banned in India
Several drugs are either banned or withdrawn after introduction in the market....
Pancreatitis
Pancreatitis or inflammation of the pancreas may show up as acute pancreatitis or chronic pain. Alco...
Tattoos A Body Art
Tattoos are a rage among college students who sport it for the ‘cool dude’ or ‘cool babe’ look...
Vaccination for Children
Vaccines are biological products that impart immunity to the recipient. Vaccines may be live attenua...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use